alalevonadifloxacin   Click here for help

GtoPdb Ligand ID: 10756

Synonyms: WCK 2349 | WCK-2349 | WCK2349
Compound class: Synthetic organic
Comment: Alalevonadifloxacin is a benzoquinolizine fluoroquinolone class antibacterial. It is being developed as a component of a combination therapy with levonadifloxacin.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 114.86
Molecular weight 431.19
XLogP 4.55
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES O=C([C@@H](N)C)OC1CCN(CC1)c1c(F)cc2c3c1CC[C@@H](n3cc(c2=O)C(=O)O)C
Isomeric SMILES O=C([C@@H](N)C)OC1CCN(CC1)c1c(F)cc2c3c1CC[C@@H](n3cc(c2=O)C(=O)O)C
InChI InChI=1S/C22H26FN3O5/c1-11-3-4-14-18-15(20(27)16(21(28)29)10-26(11)18)9-17(23)19(14)25-7-5-13(6-8-25)31-22(30)12(2)24/h9-13H,3-8,24H2,1-2H3,(H,28,29)/t11-,12-/m0/s1
InChI Key OUXXDXXQNWKOIF-RYUDHWBXSA-N
No information available.
Summary of Clinical Use Click here for help
WCK2349 has completed Phase 1 PK/PD evaluations, but does not appear to have been tested for antibacterial efficacy in infected patients.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02217930 Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers Phase 1 Interventional Wockhardt 1